Cortalix News and Events
Your source for the latest content from Cortalix news and events:
Latest News, Upcoming Events and Presentations
CORTALIX will be present at Antibody Industrial Symposium (AIS) in Tours, France, June 25-26 2025
CORTALIX AIS 2025 – Booth #51 We’re excited to announce that Cortalix will be present at the 13th Antibody Industrial Symposium (AIS 2025), taking place June 25–26 at the Palais des Congrès in Tours, France. 📍 Booth #51👤 Herman Steen (CEO) and Ronald Vos (CBO) will be...
Cortalix receives investment from Future Tech Ventures and Rabobank Innovation
Cortalix, a Groningen-based biotech start-up has received an investment of 1 million euros from Future Tech Ventures, the Rabobank Innovation Loan, and various subsidies to accelerate the development and commercialization of its single-domain antibody technology. The...
Cortalix will present at PepTalk San Diego, CA, January 13-16 2025
Herman Steen, CEO of Cortalix, will present on "Single-Domain Antibody-Based Radiopharmaceuticals for Novel Cancer Stroma Targets" at the 24th Annual PepTalk Summit US, January 13-16, 2025 in San Diego, CA. For more information about Cortalix: www.cortalix.com Contact...
Cortalix will present at Festival of Biologics in Basel, Switzerland, 15-17 October 2024
Herman Steen, CEO of Cortalix, will present a poster "A Synthetic Single-domain Antibody Discovery Platform for the Selection of Radiopharmaceuticals for Novel Fibrosis Targets" at the Festival of Biologics, October 15-17, 2024 in Basel, Switzerland. You are cordially...
Cortalix will present at TRP Berlin, Germany, 5 – 7 December 2023
Herman Steen, CEO of Cortalix, will present on "Novel Fibrosis Targets for Molecular Imaging of Fibrogenesis & Fibrotic Cancers" at the 5th Targeted Radiopharmaceuticals Summit EU 2023, December 5 - 7, 2023 in Berlin, Germany. For more information about Cortalix:...
Cortalix is awarded a EUROSTARS grant and joins the existing consortium on molecular diagnostic PET-imaging of colorectal cancer
Cortalix will join the existing consortium on a EUROSTARS grant of EUR 1.7 million for colorectal cancer molecular PET-imaging. EUROSTARS is a joint program of EUREKA and the European Commission, co-funded by the national budgets of 36 EUROSTARS Participating and...
Cortalix acquires patents and knowhow from BiOrion
Cortalix BV acquires patents and know-how from BiOrion on its single domain antibody platform and fibrogenesis biomarker radiopharmaceuticals. With these patents and know-how, Cortalix can continue to work on 2 active clinical programs around PET imaging of...
Cortalix is a member of LIFE Cooperative a regional life sciences cooperative based in Groningen, and of HollandBIO, the national biotech industry association.